hiv-infections

Documents about hiv-infections

• Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in HIV-Infected Subjects 6 Years of Age or Older Who Are Naive to Pneumococcal Vaccine#459970ClinicalTrials.gov
• Overcoming Geography With Technology: Medical Drones Project#812068ClinicalTrials.gov
• Safety and Effectiveness of Immunotherapy With Autologous HIV-Specific CD8 Cells in HIV Infected Adults#268001ClinicalTrials.gov
• Safety of and Immune Response to a Combination HIV Vaccine Regimen in HIV Uninfected Adults#481782ClinicalTrials.gov
• A Safety and Efficacy Trial of Dapivirine Vaginal Ring in Africa#812200ClinicalTrials.gov
• A Safety Study of Dapivirine (TMC120) Vaginal Microbicide Gel in Belgium#830095ClinicalTrials.gov
• Treatment for Depression Among HIV-Infected Youth#854314ClinicalTrials.gov
• Effectiveness of Armodafinil for Treating Fatigue in Adults With HIV/AIDS#856164ClinicalTrials.gov
• PD-1 Inhibition to Determine CNS Reservoir of HIV-Infection#867001ClinicalTrials.gov
• Preliminary Study of Early, Primary HIV Infection in a High Risk Cohort#889535ClinicalTrials.gov
• Epidemiological Study of the Markers of Aging in the Cohort of Patient HIV in Brest#897443ClinicalTrials.gov
• A Couples-based Intervention for Transgender Women and Their Partners#900132ClinicalTrials.gov
• Integrated drug resistance action framework for HIV, hepatitis B and C and sexually transmitted infections, 2026–2030#151807WHO IRIS
• A Phase I Maximum Tolerated Dose Study of CI-1012 in Late-Stage HIV+ Patients#876914ClinicalTrials.gov
• Evaluating Safety and Immune Response to the HIV-1 CH505 Transmitted/Founder gp120 Adjuvanted With GLA-SE in Healthy, HIV-exposed Uninfected Infants#804866ClinicalTrials.gov
• HIV Diagnosis in Hospitalized Malawian Infants#899232ClinicalTrials.gov
• Home HIV Testing for Older Adults in South Africa#28526ClinicalTrials.gov
• Phase I Study of Vaccination Schedule of Experimental HIV Vaccines#208252ClinicalTrials.gov
• Therapeutic Vaccination Followed by Treatment Interruption in HIV Infected Patients#279578ClinicalTrials.gov
• Food as Medicine for HIV and Diabetes#628663ClinicalTrials.gov
• Effect of Rosuvastatin on Endothelial Function#813046ClinicalTrials.gov
• AURORA Study-A Transformative Approach to Support PrEP Medication Persistence#847566ClinicalTrials.gov
• Test Albuvirtide in Experienced Patients#859961ClinicalTrials.gov
• Drug Interaction Study of Famotidine and Atazanavir With Ritonavir in HIV-Infected Patients#864874ClinicalTrials.gov
• Study on the Response to Tetanus Vaccination of People Living With HIV#866649ClinicalTrials.gov
• Linkage to Care - Part I#867703ClinicalTrials.gov
• HIV/STI Prevention for Drug-Involved Couples#871994ClinicalTrials.gov
• Reducing HIV Risk Among Adolescents: Evaluating HEART for Teens#876614ClinicalTrials.gov
• Venue-Based Couples CoOp in South Africa#903198ClinicalTrials.gov
• MR Imaging and MR Spectroscopy of HIV#909072ClinicalTrials.gov
• Evaluating the Safety and Immune Response of an Adenovirus-Based HIV Vaccine in HIV-Uninfected Adults#67694ClinicalTrials.gov
• Study of an HIV Preventive Vaccine Given With or Without an Adjuvant in HIV Uninfected Adults#121432ClinicalTrials.gov
• Evaluating the Safety and Immune Response to Three HIV Vaccine Schedules in Healthy, HIV-Uninfected Adults#152511ClinicalTrials.gov
• Evaluating the Safety and Drug Levels of an Antibody Against HIV in Healthy, HIV-Uninfected Adults#279554ClinicalTrials.gov
• Safety and Effectiveness of Administering an HIV Vaccine in the Groin Versus the Arm#321547ClinicalTrials.gov
• Consolidated HIV strategic information guidelines: driving impact through programme monitoring and management#376874WHO IRIS
• Report on the global action plan on HIV drug resistance 2017–2021#466859WHO IRIS
• Study of KP-1461 for the Treatment of HIV Positive Patients Who Have Failed Multiple HAART Regimens#857330ClinicalTrials.gov
• HIV PrEP Priming of Immune Effectors#889591ClinicalTrials.gov
• Immunogenetic Modulators of Mucosal Protection From HIV-1#891430ClinicalTrials.gov
• A Study of Anti-HIV Monoclonal Antibody KD-247#895209ClinicalTrials.gov
• Safety and Effectiveness of Adding PMPA Prodrug to an Anti-HIV Drug Combination to Treat HIV-Infected Patients#811365ClinicalTrials.gov
• Computerized HIV/Sexually Transmitted Disease (STD) Prevention Program#862747ClinicalTrials.gov
• An Open-Label Study of Emtricitabine in Combination With Other Antiretroviral Agents in HIV Infected Pediatric Subjects#874580ClinicalTrials.gov
• Consolidated guidelines on HIV testing services, 2019: web annex B. GRADE table: should HIV self-testing be offered as an additional HIV testing approach?#373055WHO IRIS
• Phase 1 Safety Study of Two Experimental HIV Vaccines#806647ClinicalTrials.gov
• Voluntary HIV Counseling, Testing, and Medication for Pregnant Women to Prevent Mother-to-Child HIV Transmission#844046ClinicalTrials.gov
• Safety and Effectiveness of a Combination Anti-HIV Drug Treatment#847826ClinicalTrials.gov
• The Effectiveness of HIV RNA Viral Load Testing in Determining Treatment Type in HIV-Infected Patients#881286ClinicalTrials.gov
• A Study to Evaluate the Safety and Effectiveness of HIV-1 LAI gp120 (an HIV Vaccine) Given With or Without HIV-1 MN rgp120 (Another HIV Vaccine) to HIV-Negative Volunteers#230477ClinicalTrials.gov